LONDON, Jan 8 (Reuters) - Iceland's Actavis, one of the world's top makers of generic drugs, is to be offered for sale by its private-equity owners in an auction that could raise $6 billion or more, ...

(Reuters) - Activist investor William Ackman said on Tuesday he supports the $66 billion (42.18 billion pounds) deal in which Actavis PLC (ACT.N) will buy Allergan Inc (AGN.N) and will withdraw his ...

In the nineteen-sixties, an ophthalmologist in San Francisco, Alan B. Scott, was researching a condition called strabismus, which makes people cross-eyed. He was interested in Botulinum Toxin Type A, ...

What if you put a generics company up for sale, and no one wanted to buy it? Just ask Actavis, the Iceland-based drugmaker that was put on the block after its billionaire owner lost his shirt in that ...